Mackay Shields LLC’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-204,571
Closed -$9.06M 309
2022
Q1
$9.06M Sell
204,571
-8,054
-4% -$349K 0.08% 235
2021
Q4
$9.03M Sell
212,625
-4,470
-2% -$188K 0.08% 248
2021
Q3
$9.42M Sell
217,095
-6,289
-3% -$278K 0.09% 221
2021
Q2
$9.55M Sell
223,384
-26,666
-11% -$1.12M 0.09% 219
2021
Q1
$9.66M Sell
250,050
-23,192
-8% -$878K 0.07% 294
2020
Q4
$9.82M Buy
273,242
+236
+0.1% +$8.51K 0.07% 312
2020
Q3
$10.4M Buy
273,006
+17,329
+7% +$668K 0.07% 297
2020
Q2
$8.98M Buy
255,677
+42,191
+20% +$1.52M 0.07% 302
2020
Q1
$6.97M Sell
213,486
-1,471
-0.7% -$57.5K 0.06% 328
2019
Q4
$9.72M Sell
214,957
-13,679
-6% -$572K 0.07% 331
2019
Q3
$9.3M Buy
228,636
+2,198
+1% +$93.1K 0.06% 352
2019
Q2
$9.73M Sell
226,438
-18,566
-8% -$714K 0.07% 345
2019
Q1
$9.4M Buy
245,004
+1,128
+0.5% +$43.1K 0.07% 330
2018
Q4
$8.62M Sell
243,876
-11,247
-4% -$408K 0.07% 337
2018
Q3
$9.82M Sell
255,123
-20,645
-7% -$721K 0.08% 308
2018
Q2
$9.02M Buy
275,768
+44,631
+19% +$1.35M 0.06% 359
2018
Q1
$6.32M Buy
+231,137
New +$6.28M 0.04% 456

Other funds holding BSX

Mackay Shields LLC's BSX Position: Q2 2022 in Review

Mackay Shields LLC sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 204,571 shares — an estimated $9.06M sold.

Mackay Shields LLC first reported a position in BSX in Q1 2018 and held it in 17 quarters. The position peaked at $10.4M in Q3 2020. 878 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

  • Mackay Shields LLC reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 204,571 Boston Scientific shares in Q2 2022, an estimated $9.06M.
  • Mackay Shields LLC first reported a position in Boston Scientific in Q1 2018 and held it in 17 quarters.
  • Mackay Shields LLC's Boston Scientific position peaked at $10.4M in Q3 2020.
  • 878 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.